# Novel Treatment for Coronary Artery Disease

> **NCT01228214** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of Carabobo** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** amiloride

## Key facts

- **NCT ID:** NCT01228214
- **Lead sponsor:** University of Carabobo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2013-04
- **Final completion:** 2013-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228214, "Novel Treatment for Coronary Artery Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01228214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*